Angiogenesis Inhibitors
Learn MoreHIF inhibitors are a class of compounds that hold great potential in the field of biomedical research and drug development HIF or Hypoxia-Inducible Factor is a key transcription factor that plays a crucial role in cellular responses to low oxygen levels By inhibiting HIF activity these inhibitors have the ability to modulate various biological processes including angiogenesis metabolism and inflammation With their ability to target HIF signaling pathways HIF inhibitors offer new possibilities for therapeutic interventions in diseases such as cancer cardiovascular disorders and inflammatory conditions Our company specializes in providing a range of innovative HIF inhibitors to support researchers in their quest for new treatments and improved patient outcomes
Catalog Number | Chemical Name | CAS # | Price |
---|---|---|---|
EI-0025 | 1,4-DPCA | 331830-20-7, 53946-49-9 | Online Inquiry |
EI-0337 | BAY 87-2243 | 1227158-85-1 | Online Inquiry |
EI-0583 | Chetomin | 1403-36-7 | Online Inquiry |
EI-1198 | IDF-11774 | 1429054-28-3 | Online Inquiry |
EI-1276 | KC7F2 | 927822-86-4 | Online Inquiry |
EI-1376 | LW6 | 934593-90-5 | Online Inquiry |
EI-1825 | PT-2385 | 1672665-49-4 | Online Inquiry |
EI-1830 | PX 12 | 141400-58-0 | Online Inquiry |
EI-1831 | PX-478 hydrochloride | 685898-44-6 | Online Inquiry |
HIF inhibitors have numerous applications in both research and medicine In the field of research these inhibitors are commonly used to study the role of hypoxia-inducible factor (HIF) in various biological processes By blocking the activity of HIF scientists can gain insights into how HIF affects gene expression cell survival and disease progression This knowledge can then be applied to develop new treatments and therapies
In medicine HIF inhibitors hold promise for the treatment of conditions related to abnormal HIF activity such as cancer and ischemic diseases By inhibiting HIF these inhibitors can help suppress the growth of cancer cells and reduce the formation of new blood vessels in tumors Additionally HIF inhibitors can be used to mitigate the harmful effects of hypoxia a condition characterized by insufficient oxygen supply to tissues which occurs in various diseases By targeting HIF these inhibitors can potentially improve patient outcomes and quality of life
Overall whether in basic research or clinical settings the applications of HIF inhibitors are wide-ranging and impactful offering potential advancements in understanding and treating various biological and disease processes
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.